Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
Singaporean ophthalmic disease treatment company seeks investment.
| Project region | Singapore |
|---|---|
| Industry | Biomedicine |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
David Stepat
Country Director
| Project highlights | ophthalmic diseases - 6 treatment centers - profitable |
|---|---|
| Project description |
The Singaporean company focuses on the treatment of ophthalmic diseases, including corneal transplantation, retinal surgery, myopia control and so on. There are 6 local professional treatment centers and 11 senior ophthalmologists. As of May 2021, the net profit after salaries is approximately USD 7.28 million (SGD 10 million). Now the company seeks investment. |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us